Search Results 151-160 of 16970 for Semaglutide

  1. Childhood obesity - Doctors and departments - Mayo Clinic

    Anyone taking Wegovy (semaglutide GLP-1 drug) without a gallbladder? 24 Replies Sat, Feb 21, 2026. See more discussions. Related. Mayo Clinic Children's Center ...

  2. Pegulicianine (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  3. Gemtuzumab (intravenous route) - Side effects & uses - Mayo Clinic

    Gemtuzumab injection is used alone or together with other medicines (eg, cytarabine, daunorubicin) to treat newly-diagnosed CD33-positive acute myeloid leukemia ...

  4. Pegfilgrastim-pbbk (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Pegfilgrastim-pbbk injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  5. Effects Of Niacin On Intramyocellular Fatty Acid Trafficking In Upper Body Obesity And Type 2 Diabetes Mellitus - Mayo Clinic

    Muscle insulin resistance is a hallmark of upper body obesity (UBO) and Type 2 diabetes (T2DM). It is unknown whether muscle free fatty acid (FFA) availability ...

  6. Sitagliptin (oral route) - Side effects & dosage - Mayo Clinic

    Sitagliptin is used alone or together with other medicines (eg, insulin, glimepiride, metformin, or pioglitazone) and with proper diet and exercise to treat ...

  7. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

    Glycemic control will be monitored using the Ultrahuman M1(UH-M1) continuous glucose monitoring system, while sleep and activity will be measured by the ...

  8. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest stories.

  9. Clonidine (transdermal route) - Side effects & dosage - Mayo Clinic

    This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also ...

  10. Tesamorelin (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Tesamorelin injection is a hormone similar to the one normally released from the hypothalamus gland in the brain. It is used to reduce excess fat (lipodystrophy) ...